← Back to TEVA

Teva Pharmaceutical Industries Limited American Depositary Shares financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 29/07/2026Mar 2026Filed 29/04/2026Dec 2025Filed 03/02/2026Sep 2025Filed 05/11/2025Jun 2025Filed 29/07/2026Mar 2025Filed 29/04/2026Sep 2024Filed 05/11/2025Jun 2024Filed 30/07/2025
$4,142$3,982$1,500$4,480$4,176$3,891$4,332$4,164
−$576$369$433$282$214−$437−$846
−$0.49$0.31$0.37$0.24$0.18−$0.39−$0.75
1,1651,1791,1641,1611,1591,1331,133

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.